» Protein S Immunodepleted Deficient Human Plasma

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS IMMUNODEPLETED DEFICIENT PLASMAS

Protein S Immunodepleted Deficient Human Plasma

Fresh frozen plasmas

Immunodepleted deficient plasma deficient for protein S assay.

Pooled normal citrated human plasma depleted of protein S using antibodies directed to protein S immobilized on agarose beads. Plasma contains 20 mM Hepes.

Reference	6-FDPPS-10
Presentation	Kit
Format	10 x 1.0 mL
Quote

Reference	6-FDPPS
Presentation	Bottle
Format	1 x 100 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
6-FDPPS-10	Kit	10 x 1.0 mL
6-FDPPS	Bottle	1 x 100 mL

Price list, safety data sheets and notices are accessible to our registered customers.

Protein S is a 69 kDa dependent vitamin K eglycoprotein synthesized by hepatocytes, endothelial cells, megakaryodytes and osteoblasts. It is a physiological inhibitor of coagulation. It acts as a cofactor of activated protein C by promoting inactivation by proteolysis of FVa and FVIIIa.
It inhibits the activation of prothrombin and the formation of the prothrombinase complex on phospholipids as well as the activation of FX.

Packaging in plastic cryotubes or in bottles of at least 100 mL.

Frozen, immuno-depleted plasmas are certified to have less than 1% for the deficient factor considered, both for the antigenic and functional assay in haemostasis.
This box is intended for research use

- No bovine additives
- No reconstitution error
- No deterioration of plasmas linked to freeze-drying
- Cryotubes ready to use after thawing (4 min at 37°C).

- 10 cryotubes x 1 mL or 100 mL vial of frozen plasma.

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS IMMUNODEPLETED DEFICIENT PLASMAS